المؤلفون: Ree AH; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Høye E; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Tumor Biology, Oslo University Hospital, Oslo, Norway., Esbensen Y; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Clinical Molecular Biology, Akershus University Hospital, Lørenskog, Norway., Beitnes AR; Department of Pathology, Akershus University Hospital, Lørenskog, Norway., Negård A; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Radiology, Akershus University Hospital, Lørenskog, Norway., Bernklev L; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Tetlie LK; Department of Oncology, Sørlandet Hospital, Kristiansand, Norway., Fretland ÅA; The Intervention Centre and Department of Hepato-Pancreato-Biliary Surgery, Oslo University Hospital, Oslo, Norway., Hamre HM; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Kersten C; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Department of Research, Sørlandet Hospital, Kristiansand, Norway., Hofsli E; Department of Oncology, St. Olav's Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Guren MG; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Sorbye H; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Nilsen HL; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Clinical Molecular Biology, Akershus University Hospital, Lørenskog, Norway.; Department of Microbiology, Oslo University Hospital, Oslo, Norway., Flatmark K; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Tumor Biology, Oslo University Hospital, Oslo, Norway.; Department of Gastroenterological Surgery, Oslo University Hospital, Oslo, Norway., Meltzer S; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.

المصدر: Oncoimmunology [Oncoimmunology] 2024 Jun 28; Vol. 13 (1), pp. 2372886. Date of Electronic Publication: 2024 Jun 28 (Print Publication: 2024).

نوع المنشور: Journal Article; Case Reports; Randomized Controlled Trial

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

مواضيع طبية MeSH: Oxaliplatin*/therapeutic use , Oxaliplatin*/administration & dosage , Proto-Oncogene Proteins B-raf*/genetics , Proto-Oncogene Proteins B-raf*/antagonists & inhibitors , Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/pathology , Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/pharmacology , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Female ; Aged ; Mutation ; Microsatellite Instability/drug effects ; Treatment Outcome ; Aged, 80 and over

المؤلفون: Ree AH; Department of Oncology, Akershus University Hospital, Lørenskog, Norway. a.h.ree@medisin.uio.no.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. a.h.ree@medisin.uio.no., Šaltytė Benth J; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway., Hamre HM; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Kersten C; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Department of Research, Sørlandet Hospital, Kristiansand, Norway., Hofsli E; Department of Oncology, St Olav's Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Guren MG; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Sorbye H; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Johansen C; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Negård A; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Radiology, Akershus University Hospital, Lørenskog, Norway., Bjørnetrø T; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Nilsen HL; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Clinical Molecular Biology, Akershus University Hospital, Lørenskog, Norway., Berg JP; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway., Flatmark K; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterological Surgery, Oslo University Hospital, Oslo, Norway.; Department of Tumour Biology, Oslo University Hospital, Oslo, Norway., Meltzer S; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.

المصدر: British journal of cancer [Br J Cancer] 2024 Jun; Vol. 130 (12), pp. 1921-1928. Date of Electronic Publication: 2024 Apr 25.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Nivolumab*/therapeutic use , Nivolumab*/administration & dosage , Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/pathology , Oxaliplatin*/administration & dosage , Oxaliplatin*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Aged ; Microsatellite Instability ; Progression-Free Survival ; Adult ; Neoplasm Metastasis ; Immune Checkpoint Inhibitors/therapeutic use ; Proto-Oncogene Proteins p21(ras)/genetics

المؤلفون: Malik YG; Department of Digestive Surgery, Akershus University Hospital, Lorenskog, Norway., Benth JŠ; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Health Services Research Unit, Akershus University Hospital, Lorenskog, Norway., Hamre HM; Department of Internal Medicine, Oncology, Akershus University Hospital, Lorenskog, Norway., Faerden AE; Department of Digestive Surgery, Akershus University Hospital, Lorenskog, Norway., Ignjatovic D; Department of Digestive Surgery, Akershus University Hospital, Lorenskog, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Schultz JK; Department of Digestive Surgery, Akershus University Hospital, Lorenskog, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Pediatric and Digestive Surgery, Oslo University Hospital, Oslo, Norway.

المصدر: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland [Colorectal Dis] 2024 Jan; Vol. 26 (1), pp. 22-33. Date of Electronic Publication: 2023 Nov 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Blackwell Science Ltd Country of Publication: England NLM ID: 100883611 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1318 (Electronic) Linking ISSN: 14628910 NLM ISO Abbreviation: Colorectal Dis Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Survivors* , Colonic Neoplasms*/drug therapy , Colonic Neoplasms*/surgery, Humans ; Aged ; Quality of Life ; Cohort Studies ; Neoplasm Recurrence, Local ; Chemotherapy, Adjuvant/methods ; Registries

المؤلفون: Meltzer S; Department of Oncology, Akershus University Hospital, Lørenskog, Norway. sebastian.meltzer@medisin.uio.no., Negård A; Department of Radiology, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Bakke KM; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Hamre HM; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Kersten C; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Department of Research, Sørlandet Hospital, Kristiansand, Norway., Hofsli E; Department of Oncology, St. Olav's Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Guren MG; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Sorbye H; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Flatmark K; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterological Surgery, Oslo University Hospital, Oslo, Norway.; Department of Tumour Biology, Oslo University Hospital, Oslo, Norway., Ree AH; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

المصدر: British journal of cancer [Br J Cancer] 2022 Dec; Vol. 127 (12), pp. 2227-2233. Date of Electronic Publication: 2022 Oct 13.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/diagnostic imaging , Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/genetics , Immune Checkpoint Inhibitors*, Humans ; DNA Mismatch Repair

المؤلفون: Lie HC; Department of Behavioural Sciences in Medicine, University of Oslo, Oslo, Norway; National Advisory Unit on Late Effects after Cancer Treatment, Oslo University Hospital, Radiumhospitalet, Oslo, Norway. Electronic address: h.c.lie@medisin.uio.no., Loge JH; Department of Behavioural Sciences in Medicine, University of Oslo, Oslo, Norway; National Advisory Unit on Late Effects after Cancer Treatment, Oslo University Hospital, Radiumhospitalet, Oslo, Norway., Fosså SD; National Advisory Unit on Late Effects after Cancer Treatment, Oslo University Hospital, Radiumhospitalet, Oslo, Norway., Hamre HM; National Advisory Unit on Late Effects after Cancer Treatment, Oslo University Hospital, Radiumhospitalet, Oslo, Norway., Hess SL; National Advisory Unit on Late Effects after Cancer Treatment, Oslo University Hospital, Radiumhospitalet, Oslo, Norway., Mellblom AV; Department of Behavioural Sciences in Medicine, University of Oslo, Oslo, Norway., Ruud E; Department of Paediatric Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Finset A; Department of Behavioural Sciences in Medicine, University of Oslo, Oslo, Norway.

المصدر: Patient education and counseling [Patient Educ Couns] 2015 May; Vol. 98 (5), pp. 604-11. Date of Electronic Publication: 2015 Jan 31.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: Ireland NLM ID: 8406280 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5134 (Electronic) Linking ISSN: 07383991 NLM ISO Abbreviation: Patient Educ Couns

مواضيع طبية MeSH: Health Knowledge, Attitudes, Practice* , Patient Education as Topic*/methods , Patient Preference*, Long Term Adverse Effects/*etiology , Lymphoma/*rehabilitation , Survivors/*psychology, Adolescent ; Adult ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Communication ; Drug-Related Side Effects and Adverse Reactions/psychology ; Female ; Focus Groups ; Humans ; Interviews as Topic ; Long Term Adverse Effects/psychology ; Lymphoma/therapy ; Male ; Needs Assessment ; Physician-Patient Relations ; Young Adult

المؤلفون: Kanellopoulos A; Department of Paediatric Medicine, Women and Children's Division, Oslo University Hospital, Rikshospitalet, Oslo, Norway. adriani.kanellopoulos@medisin.uio.no, Hamre HM, Dahl AA, Fosså SD, Ruud E

المصدر: Pediatric blood & cancer [Pediatr Blood Cancer] 2013 May; Vol. 60 (5), pp. 849-55. Date of Electronic Publication: 2013 Jan 17.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma*/epidemiology , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/epidemiology , Quality of Life*, Survivors/*psychology, Adolescent ; Adult ; Anxiety/epidemiology ; Cross-Sectional Studies ; Depression/epidemiology ; Fatigue/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Obesity/epidemiology ; Sleep Initiation and Maintenance Disorders/epidemiology ; Surveys and Questionnaires ; Young Adult

عنوان ترانسليتريتد: Barnekreft og fertilitet.

المؤلفون: Fosså SD, Hamre HM

المصدر: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2011 Aug 09; Vol. 131 (15), pp. 1412.

نوع المنشور: Editorial

بيانات الدورية: Publisher: Norske Laegeforening Country of Publication: Norway NLM ID: 0413423 Publication Model: Print Cited Medium: Internet ISSN: 0807-7096 (Electronic) Linking ISSN: 00292001 NLM ISO Abbreviation: Tidsskr Nor Laegeforen Subsets: MEDLINE

مواضيع طبية MeSH: Fertility*, Infertility/*etiology , Neoplasms/*complications, Adult ; Child ; Female ; Humans ; Infertility/therapy ; Male ; Neoplasms/therapy ; Survivors